Commitment to B-lymphocyte differentiation is characterized by expression of the B220 form of the common leukocyte antigen (Ly-5) and D-J, rearrangement of the Ig heavy chain gene complex. B-lineage progenitor cells, or pro-B cells, that have initiated Ig gene rearrangement, but do not express detectable Ig heavy or light chain protein, have recently been shown to retain substantial capacity for expansion in vitro in the presence of bone marrow (BM) stromal cells and interleukin-7 (IL-7). Although the potentiating effect of stromal cells on pro-B-cell proliferation can be partially attributed to the ligand for the proto-oncogene receptor c-kit (c-kit ligand [KL] or stem cell factor), several lines of evidence suggest that c-kit-mediated cell signalling is not required for pro-B-cell expansion. Previous studies from this laboratory demonstrated that insulin-like growth factor-1 (IGF-1) potentiated the proliferative effect of IL-7 on nonadherent cells from lymphoid long-term BM cultures in a manner similar to that shown for KL. To further delineate specific cell stages that respond to lymphopoietic cytokines, we derived continuously proliferating pro-B-cell lines from day-I4 murine fetal liver in the presence of IL-7 and BM stromal cell clone S10. Initial expansion and continued proliferation of these pro-B-cell AINTENANCE of hematopoiesis and effective pro-
chain gene complex. B-lineage progenitor cells, or pro-B cells, that have initiated Ig gene rearrangement, but do not express detectable Ig heavy or light chain protein, have recently been shown to retain substantial capacity for expansion in vitro in the presence of bone marrow (BM) stromal cells and interleukin-7 (IL-7). Although the potentiating effect of stromal cells on pro-B-cell proliferation can be partially attributed to the ligand for the proto-oncogene receptor c-kit (c-kit ligand [KL] or stem cell factor), several lines of evidence suggest that c-kit-mediated cell signalling is not required for pro-B-cell expansion. Previous studies from this laboratory demonstrated that insulin-like growth factor-1 (IGF-1) potentiated the proliferative effect of IL-7 on nonadherent cells from lymphoid long-term BM cultures in a manner similar to that shown for KL. To further delineate specific cell stages that respond to lymphopoietic cytokines, we derived continuously proliferating pro-B-cell lines from day-I4 murine fetal liver in the presence of IL-7 and BM stromal cell clone S10. Initial expansion and continued proliferation of these pro-B-cell AINTENANCE of hematopoiesis and effective pro-M duction of functional subsets of blood borne cells from a limited reserve of hematopoietic stem cells requires substantial expansion of committed hematopoietic progenitor cells for each cell lineage. For that reason, it is essential to understand mechanisms of self-renewal and expansion of specific progenitor cell types that precede their differentiation and exit from cell cycle as functional progeny. In the developing B-lymphocyte lineage, this phase of progenitor cell expansion is accompanied by Ig gene rearrangement and Ig repertoire diversification that results in continuous production of an appropriate array of immunocompetent clonotypes.' Although pre-B cells were originally thought to undergo expansion in vivo, kinetic studies showed little or no cell renewal potential after p-heavy chain synthesis.2 Recent studies have focused on developmentally earlier B-cell progenitors, or pro-B cells, that are characterized by gene rearrangement at the Ig DJ, locus, but lack detectable V, rearrangement or cytoplasmic expression of p-heavy chain (cp) protein.324 These pro-B cells can be expanded from normal fetal liver or bone marrow and cloned in vitro in the presence of bone marrow (BM) stromal cells and exogenous interleukin-7 (IL-7). 5 Expansion of pro-B cells in vitro requires the presence of both IL-7 and BM stromal cells.5 Although the complex role of stromal cells in this process has not been fully elucidated, studies from a number of laboratories have shown that the ligand for the c-kit receptor (c-kit ligand [KL] ) is produced by BM stromal cells and may explain, in part, their contribution to pro-B-cell renewal.&* Although this effect has not previously been directly shown using pro-B-cell clones, it is consistent with studies that addressed the potentiating effect of KL on proliferation of cells from long-term BM cultures6 lines was absolutely dependent on the presence of both IL-7 and stromal cells. In the absence of KL, IL-7-stimulated proliferation of these cells in short-term cultures and addition of either recombinant IGF-1 or KL significantly potentiated this proliferative response. Although IGF-2 and insulin also potentiated the effect of IL-7, our data suggest that neither IGF-2 nor insulin represent normal regulators of intramyeloid lymphocyte development. IGF-1 and KL activate unique cascades of intracellular signalling events and inclusion of both cytokines in cultures of IL-7-stimulated pro-B cells resulted in additive potentiation of the proliferative response. Taken together, these results suggest that expansion of pro-B cells in vivo is maintained by at least three stromal cell-derived cytokines. IL-7 appears to be unique in delivering the primary proliferative signal for pro-B-cell expansion; however, both KL and IGF-1 potentiate the proliferative effect of IL-7 on these cells. Srrornal cdl lines. Characterization and maintenance of BM stromal cell line SI0 has been previously described in detail.13 Briefly, stromal cells were grown to confluence in 25-cm2 orJ5-cm2 flasks in @-Modified Eagle's Medium (nMEM: GIBCO, Grand Island, NY) containing 5% fetal calf serum (Hyclone Lot No. I I I I 1041; Hyclone, Logan, UT). Cells were passaged weekly by trypsinization.
Derivation of pro-B-cell lines and clones has been described in detail.' Briefly, day-I4 fetal livers were removed and dispersed into single-cell suspensions by repeated aspiration through progressively smaller bore hypodermic needles ( 1 8 to 22 gauge). Pro-B-cell lines were derived by serially passaging day-14 fetal liver nonadherent cells in the presence of BM stromal cell line SI0 and 50 U/mL recombinant murine IL-7. Cells that proliferated for 4 weeks in vitro were expanded in bulk culture under the same conditions and camed as a fetal liver cell line (FL). 
Nzrore.vcence microscopy.
with FITC-goat antirat Ig (SBA). Cells were washed to remove excess antibody and examined by epi-fluorescent microscopy.
For Ig gene rearrangement analysis. high molecular weight DNA was organically extracted from 2 X IO'cellsand precipitated with 10090 EtOH. DNA was air-dried. resuspended in 100 pL dH,O. and restricted with 20 U EcoRl for 6 to 8 hours at 37°C. DNA was then reprecipitated with 2 vol of 100% EtOH in the presence of 20 p g Esclwriclfia coli tRNA as camer for use as polymerase chain reaction (PCR) template. Ig heavy chain gene rearrangement status was determined using primer sets that defined intervening sequence 5'of D,,,, and 5' of JHI (Fig I) . The sequence of primer sets used was exactly as previously reported.' Amplification was performed for 35 cycles with denaturation at 95°C for I minute, annealing at 58°C for 3 minutes, and extension for 4 minutes at 72°C. with an additional I5-minute extension added to the final cycle. Germline configuration was confirmed with identically prepared DNA samples from stromal cell line S IO. Amplification ofglucose-aldehyde-phosphate dehydrogenase (GAPDH) using primer sets previously described" was used throughout as a control for template integrity and normalization of data to a constitutively expressed transcript. PCR products were separated on 2% ethidium bromide-stained agarose gels and photographed for densitometric analysis using BioScan Optimas (BioScan, Inc. Edmunds. WA).
Proljfi~rarion Where indicated, KL (100 ng/mL), IGF-I (5 to 100 ng/mL), IGF-2 (5 to 100 ng/mL), insulin (5 to IO0 ng/mL), or IL-7 (50 U/mL) were added to these cultures. Wells were pulsed with I pCi 3H-TdR at 24 hours and harvested 18 hours later onto glass wool fiber strips with an automated cell harvester (Cambridge Instruments, Boston, MA). Incorporated radioactivity was determined by liquid scintillation counting (LKB/Wallac Model 1410; Gaithersburg, MD) in an aqueous fluor (Biosafe-11; Research Products International, Mount Prospect, IL).
RESULTS

Derivation of pro-B-cell lines.
To directly investigate the effect of insulin-like growth factors on pro-B-cell proliferation, we initiated cultures of day-14 murine fetal liver cells on BM stromal cell line SI0 in the presence of 50 U/ mL of IL-7 as previously de~cribed.~ As noted in that study, addition of exogenous IL-7 was absolutely required to maintain lymphoid cell proliferation in these cultures. Cells passaged under these conditions for at least 4 weeks were used in all studies. Nonadherent cells from the uncloned pro-B-cell line (FL) and a panel of cloned derivatives of this cell line were morphologically identical and characterized as large to medium immature lymphoid cells with characteristic large nucleus to cytoplasmic ratio and leptochromatic nuclear morphology. This cell morphology is consistent with that previously described for fetal liver and BM B-cell precursors. l5 The cell surface molecule Ly-5, or the common leukocyte antigen (CD45), is expressed differentially on hemopoietic lineages. B-lineage cells in the marrow express the 220-Kd form of this molecule (B220) with initiation of expression apparently coincident with initial rearrangement of Ig heavy chain genes.' We found that the majority of uncloned culture expanded pro-B cells expressed the B220 form of Ly-5, but did not have detectable cytoplasmic or cell surface expression of heavy or light chain Ig protein (Table 1) .
Cloned pro-B-cell line derivatives of FL, of which C 1.92 is representative, did not express B220 or detectable Ig heavy or light chain protein (Table 1) . However, subsequent to the completion of data for this report, this cell line initiated B220 expression and has remained B220+ in continuous culture (data not shown). This alteration in B220 expression at 12 to 15 weeks of continuous culture did not correlate with a change in cell morphology, Ig protein expression, or characteristic pattern of Ig gene rearrangement (see below). change in cytokine or stromal dependence or proliferative response in the studies similar to those reported here (data not shown).
To further confirm the developmental staging of pro-B-cell lines used in this study, Ig gene rearrangements were evaluated using PCR amplification of germline sequence 5' of JH1 and 5' of D,,,,, (Fig 1) . This strategy has been used previously to detect loss of germline sequence after D --+ JH and V, --* DJH rearrangements, re~pectively.~ As shown in Fig 1, both FL and its cloned derivative C 1.92 had apparent complete rearrangement at the DJH locus, indicated by absence of amplifiable sequence 5' of JH1-specific amplicon (572-bp amplicon). As previously described for pro-B cells,3" both FL and clone C1.92 retained 5' amplifiable sequence, showing at least some remaining germline configuration of the VH-D locus (Fig 1) . Densitometry of these amplicons, and comparison to GAPDH and stromal cell controls, suggested that FL and C 1.92 were unrearranged at the VH-D locus on both alleles (data not shown). However, verification of this phenotype will require PCR primer strategies that show amplicon appearance after Ig rearrangement. The Ig gene rearrangement status and lack of expression of Ig heavy or light chain gene products in these pro-B-cell lines is consistent with that previously reported for early IL-7 and stromal cell-dependent pro-B-cell lines.'
Only IL-7 directly stimulated pro-B-cell proliferation. Both FL and C1.92 proliferated in short-term cultures containing only IL-7 (Figs 2 and 3) . However, these cells could not be maintained for extended periods (>2 days) in the absence of stromal cells (data not presented). Neither IGF-1, insulin, IGF-2, nor KL stimulated proliferation of pro-B cells in the absence of IL-7 at any concentration tested (Figs 2 and 3) .
Pro-B-cell proliferation is potentiated by IGF-I, insulin, IGF-2, and KL. Addition of IGF-1 to cultures of pro-B
cells that contained saturating levels of IL-7 resulted in marked amplification of the proliferative response for all of the cell lines tested. This effect is shown here using both the uncloned cell line FL (Fig 2) and a cloned derivative line, C1.92 (Fig 3) . Similar results were observed with 5 additional independent pro-B-cell lines established from day-1 3 to day-16 fetal livers (data not presented). Optimal potentiation of IL-7-mediated proliferation was achieved with 20 to 100 ng/mL recombinant IGF-1 and this effect was essentially identical to that found with saturating concentrations of KL (100 ng/mL; Figs 2 and 3).
It is well documented in several experimental systems that IGF-1 and the structurally related cytokines IGF-2 and insulin often stimulate the same cell types. For that reason, we investigated the effect of IGF-2 and insulin on expanded cultures of pro-B cells. IGF-2 potentiated the effect of IL-7 on proliferation of the pro-B-cell line C 1.92 (Fig 3) , but had no effect when added to cultures in the absence of IL-7. However, IL-7 potentiation was achieved with a lower concentration of IGF-1 (20 ng/mL) than with IGF-2 (100 ng/ mL). Although insulin appeared to minimally potentiate the effect of IL-7 at a low concentration (20 ng/mL), this result was both significantly lower than that achieved with either IGF-1 or IGF-2 and no elevation of nucleotide incorporation was achieved by increasing concentrations of insulin (Fig 3) .
In some experiments, duplicate cultures were analyzed in the absence of serum. No significant differences in 3H-TdR incorporation were found between cultures that contained either no serum or 5% of the selected batch of serum used in this study (data not presented).
The eflects of IGF-1 and KL are additive on pro-B-cell lines.
Intracellular events that accompany IGF-I receptor binding and KL binding are known to differ, suggesting that these two cytokines potentiate IL-7 stimulation by independent molecular mechanisms. As shown in Fig 4, when IGF-1 (20 ng/mL) and KL (100 ng/mL) were added to cultures of C1.92 cells that also contained saturating levels of IL-7, pro-B-cell proliferation was further enhanced as compared to cultures that contained either IGF-1 or KL (Fig 4) . This enhanced proliferative effect in the presence of both IGF-1 and KL was additive and could not be reproduced by increasing the concentration of either single cytokine over a wide concentration range (2 to 500 ng/mL; data not presented).
DISCUSSION
The regulatory role of stromal cells in proliferation and differentiation of immature B-lineage cells has been well d0~umented.l~ Previous studies of BM stromal cell clones have shown that, whereas cell contact is clearly important, most of the regulatory effects described for these cells can be attributed to secreted c y t o k i n e~.~~~* , '~, '~ It is also clear that the full complement of stromal cell-derived signals necessary for pro-B-cell expansion and differentiation is not yet known. It has been generally accepted that proliferation of pro-B cells in hematopoietic tissues requires the presence of both IL-7 and additional stromal cell-derived We and others have previously shown that stromal cell-derived KL potentiated the proliferative effect of IL-7 on heterogeneous long-term BM culture
We also reported that IGF-1 potentiated the proliferative effect of IL-7 on nonadherent lymphoid long-term BM culture cells in a manner analogous to that described for KL." In the present report, we show that cloned fetal liver pro-B-cell lines that have initiated Ig heavy chain rearrangement but do not yet express Ig protein proliferated in the presence of IL-7 alone. This proliferative activity of IL-7 was significantly potentiated by either IGF-I or KL and inclusion of both IGF-1 and KL resulted in additive potentiation of the proliferative effect of IL-7. This additive effect of IGF-1 and KL presumably reflects the activation of separable intracellular signalling mechanisms that result in maximal potentiation of IL-7 function.
IL-7 was originally described as a cytokine secreted by BM stromal cells that stimulated proliferation of pre-B cells." Subsequent studies have shown that IL-7 is functionally pleiotropic and stimulates proliferation of both immature2' and mature T lymphocytes.2' It has also been generally accepted that proliferation of early B-lineage cells, or pro-B cells, requires stromal cell-associated signalling in addition to IL-7 and that ability to respond to I L 7 alone is acquired relatively late in this developmental pathway.2z However, studies with isolated human B-cell precursors suggested that target cells for IL-7 were likely earlier developmentally than pre-B cells characterized by cp expre~sion.'~ We have directly addressed this question in the present study using a set of pro-B-cell lines derived from day-14 fetal liver. These pro-B-cell lines were characterized by partial rearrangement of the Ig heavy chain locus and lack of expression of Ig heavy chain protein, a phenotype consistent with previous
All of the pro-B-cell clones tested proliferated in response to IL-7 stimulation alone.
We previously demonstrated that proliferation of lymphoid cells from long-term BM cultures could be enhanced by coculture with BM stromal c e k 6 The potentiating effect of stromal cells could be reproduced, in part, with recombinant KL, a cytokine produced by the BM stromal cell line used in that study. 6 We also showed that IGF-1 stimulated differentiation of pro-B cells in the complex environment of the BM, and enhanced the proliferation of nonadherent cells from long-term BM cultures.12 The experiments presented herein show that both KL and IGF-1 potentiate the proliferative effect of IL-7 on isolated fetal liver pro-B-cell lines as well. These data firmly establish that the effect of IGF-1 is direct on B-lineage cells and that IGF-1 -responsive cells include pro-B cells that have initiated D-J, rearrangement, but lack cp-heavy chain expression.
Proliferation of IL-7-dependent pro-B-cell lines was also potentiated by both IGF-2 and insulin, albeit to a lesser degree than that found with either IGF-1 or KL. It is known that there is some cross-reactivity of insulin family cytokines with regard to binding to specific receptors for IGF-1, IGF-2, and insulin.24 Because ofthe possibility that the activity of IGF-2 or insulin was due to binding to the IGF-1 receptor, we addressed the question of whether pro-B cells express receptors for all three cytokines using previously described primer s e d 6 in reverse transcriptase PCR analyses (unpublished data). This analysis showed that pro-B cells have mRNA transcripts for both IGF-1 and insulin receptors, but no IGF-2 receptor transcripts were detected. Although these experiments did not quantitate the relative abundance of receptor mRNAs nor the actual expression of functional receptors on the cell surface, they are consistent with both previously published dataz4 and the biologic data presented here for pro-B cells. That is, the potentiating effect of IGF-1 is approximately fivefold to 10-fold higher than that found for IGF-2. This reduced effectiveness of IGF-2 correlates with the known lower affinity of IGF-1 receptor for IGF-2 compared with its cognate cytokine. The effect of insulin, on the other hand, is minimal and it seems highly unlikely that insulin is a biologically relevant ligand for this proliferative activity. However, these data do not rule out the possibility that insulin could significantly potentiate pro-B-cell proliferation at high concentrations. Interestingly, insulin has been reported to enhance growth potential of early B-lineage cells in limiting dilution assays25
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The role of IGF-1 in proliferation and differentiation of pro-B cells has only recently been appreciated." Like KL, IGF-I is a pleiotropic cytokine, with endocrine effects on somatic cell growth, as well as paracrine effects on proliferation and differentiation of a number of developing cell lineage~.'"~' We reported previously that stromal cell production of IGF-1 was necessary for differentiation of BM pro-B cells to p-heavy chain expression in vitro." Clinically, the association of IGF-I deficiency and B-cell immunodeficiency has also been well and one recent report showed a similar immunodeficiency syndrome in mice rendered IGF-1 deficient by administration ofantibodies to tumor necrosis factor It seems reasonable, then, to now include IGF-I as an essential component of stromal cell-regulated B lymphopoiesis.
Our data suggest that IGF-I and KL have both redundant and additive amplifying functions in the expansion of pro-B cells in the presence of IL-7. The functional redundancy of this amplification signal would largely explain the failure to find defects in pre-B-cell production in W-anemic mice that lack functional c-kit receptor^^^'^ or in mice treated with blocking antibodies to c-kit." However, the observation that the effects of IGF-1 and KL are additive on pro-B cells in the presence of IL-7 and that IGF-1 is required for differentiation to cp expression suggests that, at least in embryonic development, both cytokines may be required for normal expansion and differentiation of progenitor cells for the developing B lineage. It will now be important to address the mechanisms by which stromal cell production of IGF-1 and KL are regulated and to investigate specific intracellular events that accompany ligand binding and result in differential regulation of pro-B-cell proliferation and differentiation. It will also be essential to determine whether similar proliferative activity can be shown with BM pro-B cells and whether fetal or postnatal cells differ in regulation of their developmental options.
